UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Elmwood Wealth Management Inc.

Elmwood Wealth Management Inc. reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.1% during the 4th quarter, Holdings Channel.com reports. The fund owned 5,603 shares of the healthcare conglomerate’s stock after selling 120 shares during the quarter. Elmwood Wealth Management Inc.’s holdings in UnitedHealth Group were worth $2,834,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. State Street Corp boosted its holdings in shares of UnitedHealth Group by 1.3% in the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock valued at $26,626,387,000 after acquiring an additional 563,554 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of UnitedHealth Group by 1.6% in the third quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate’s stock valued at $11,440,133,000 after acquiring an additional 318,039 shares in the last quarter. Franklin Resources Inc. boosted its holdings in shares of UnitedHealth Group by 2.5% in the third quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock valued at $4,884,019,000 after acquiring an additional 193,800 shares in the last quarter. International Assets Investment Management LLC boosted its holdings in shares of UnitedHealth Group by 78,814.4% in the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after acquiring an additional 5,290,025 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in UnitedHealth Group by 30.0% during the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after buying an additional 880,183 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on UNH. Cantor Fitzgerald boosted their price objective on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday, October 16th. Bank of America decreased their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Hsbc Global Res downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Deutsche Bank Aktiengesellschaft upped their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Finally, Piper Sandler reduced their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Two equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of “Buy” and an average target price of $626.79.

UnitedHealth Group Trading Up 4.1 %

NYSE:UNH traded up $21.57 during trading hours on Monday, reaching $542.26. 4,448,515 shares of the company were exchanged, compared to its average volume of 4,219,169. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The firm has a market cap of $499.03 billion, a price-to-earnings ratio of 35.33, a PEG ratio of 1.53 and a beta of 0.62. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The stock has a 50 day simple moving average of $555.25 and a 200 day simple moving average of $562.50.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. During the same quarter last year, the firm posted $6.56 EPS. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. As a group, analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.55%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.